5. Application of bacteriocins from PARAGEN
This section details two concrete applications of these bacteriocins from the PARAGEN collection, demonstrating their potential as therapeutic agents against skin infections and in the fight against resistant strains of serious diseases such as tuberculosis. These examples illustrate the innovation and effectiveness of bacteriocins in the "One Health" concept in human health, and show that they offer a viable alternative to conventional methods and pave the way for more targeted treatments.
5.1 Treatment of S. aureus skin infections with selective bacteriocins
In a climate of increasing antibiotic resistance, Staphylococcus aureus is emerging as a critical global health issue. Recognized as one of the main causes of mortality linked to antibiotic resistance...
The Ultimate Scientific and Technical Reference
This article is included in
Bioprocesses and bioproductions
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Application of bacteriocins from PARAGEN
Challenges and prospects in the use of bacteriocins
Bibliography
Patents
Controlled growth of microorganisms. US Patent 9,333,227 / 10,188,114 + CN Patent ZL 201480057387.2 + EP3035802B1 + BR1120160035330 + IN389267
Engineering bacteriocins. US Patent Application 62681529 (filed June 6, 2018)
Bacteriocin for new application. Patent Application 2022/253743 A1 (filed 30 May 2022)
Cerein 7B bacteriocin for new application. Patent...
The Ultimate Scientific and Technical Reference
